Shingrix linked to substantial reduction in diagnoses in the six years after people received the shot
Researchers have raised hopes for delaying dementia after finding that a recently approved shingles vaccine was linked to a substantial reduction in diagnoses of the condition in the six years after receiving the shot.
The discovery, based on US medical records, suggests that beyond the health benefits of preventing shingles, a painful and sometimes serious condition in elderly people, the vaccine may also delay the onset of dementia, the UK’s leading cause of death.
About Author
More Stories
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict